|Generate QR code
Open Access
Subscription Access
Smallpox and monkeypox: characterization of viruses and prevention of infections
https://doi.org/10.29235/1818-9857-2023-02-38-42
Abstract
This review addresses the poxviruses which are the most dangerous and urgent biological threats, especially smallpox and monkeypox. The authors discuss general characteristics of viruses, historical aspects of diseases caused by these pathogens, vaccination and control and treatment of viral infections.
About the Authors
D. Babrukevich
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
Darya Babrukevich
A. Hancharou
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
Andrei Hancharou
N. Antonevich
Институт биофизики и клеточной инженерии НАН Беларуси
Belarus
Belarus
Natalia Antonevich
V. Bogdan
Отделение медицинских наук НАН Беларуси
Belarus
Belarus
Vasily Bogdan
References
1. Smallpox and Monkeypox Viruses / S. Parker [et al.] // Encyclopedia of Virology. 2008. 3rd edition. P. 639–644.
2. The Origin of the Variola Virus / I. V. Babkin, I. N. Babkina // Viruses. 2015. Vol. 7, №3. P. 1100–1112.
3. History of Smallpox and Its Spread in Human Populations / C. Thèves, E. Crubezy, P. Biagini // Microbiology Spectrum. 2016. Vol. 4, №4. Р. 1–10.
4. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From? / G. Tiecco [et al.] // Viruses. 2022. Vol. 14, №9. Р. 1–13.
5. Preparedness for a monkeypox outbreak / Q. Luo, J. Han // Infectious Medicine. 2022. Vol.1, №2. P. 124–134.
6. Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution / E. Alakunle [et al.] // Viruses. 2020. Vol. 12, №11. Article 1257. doi:10.3390/v12111257.
7. World Health Organization // https://www.who.int.
8. Gruber Marion F. Current status of monkeypox vaccines / Marion F. Gruber // npj Vaccines. 2022. Vol. 94, №7. P. 1–3.
9. Preparedness for a monkeypox outbreak / Q. Luo, J. Han // Infectious Medicine. 2022. Vol.1, №2. P. 124–134.
10. Prevention and Treatment of Monkeypox / John G. Rizk [et al.] // Drugs. 2022. Vol.82. P. 957–963.
11. Challenges and Achievements in Prevention and Treatment of Smallpox / S. Melamed, T. Israely, N. Paran // Vaccines. 2018. Vol. 6, №1. P. 1–20.
12. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox / T. Kaever [et al.] // J. Virol. 2016. Vol. 90, №9. P. 4334–4345.
13. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks / Md. Rabiul Islam [et al.] // Health Science Reports. 2022. Vol. 5, №5. P. 1–10.
14. Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections / I. Gilchuk [et al.] // Cell. 2016. Vol. 167, №3. P. 684–694.
15. A Cross-Sectional Serosurvey of Anti-Orthopoxvirus Antibodies in Central and Western Africa / Siv Aina J. Leendertz [et al.] // Viruses. 2017. Vol. 9, №10. P. 1–12.
Review
For citations:
Babrukevich D., Hancharou A., Antonevich N., Bogdan V. Smallpox and monkeypox: characterization of viruses and prevention of infections. Science and Innovations. 2023;(2):38-42. (In Russ.) https://doi.org/10.29235/1818-9857-2023-02-38-42
Views: 203
Email this article 